Glaukos Corp (GKOS)
144.00
+3.17
(+2.25%)
USD |
NYSE |
Nov 22, 16:00
144.11
+0.11
(+0.08%)
After-Hours: 20:00
Glaukos Free Cash Flow: -81.27M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -81.27M |
| June 30, 2024 | -81.76M |
| March 31, 2024 | -75.17M |
| December 31, 2023 | -78.01M |
| September 30, 2023 | -75.48M |
| June 30, 2023 | -96.51M |
| March 31, 2023 | -104.19M |
| December 31, 2022 | -63.35M |
| September 30, 2022 | -64.97M |
| June 30, 2022 | -24.54M |
| March 31, 2022 | -6.903M |
| December 31, 2021 | -23.08M |
| September 30, 2021 | -0.64M |
| June 30, 2021 | -19.36M |
| March 31, 2021 | -29.05M |
| December 31, 2020 | -29.92M |
| September 30, 2020 | -43.77M |
| June 30, 2020 | -36.91M |
| March 31, 2020 | -18.53M |
| December 31, 2019 | -5.093M |
| Date | Value |
|---|---|
| September 30, 2019 | 9.838M |
| June 30, 2019 | 17.47M |
| March 31, 2019 | 15.80M |
| December 31, 2018 | 8.549M |
| September 30, 2018 | 9.607M |
| June 30, 2018 | 10.58M |
| March 31, 2018 | 10.52M |
| December 31, 2017 | 19.78M |
| September 30, 2017 | 10.41M |
| June 30, 2017 | 6.715M |
| March 31, 2017 | 8.911M |
| December 31, 2016 | 6.031M |
| September 30, 2016 | 3.85M |
| June 30, 2016 | 2.198M |
| March 31, 2016 | -3.131M |
| December 31, 2015 | -3.065M |
| September 30, 2015 | -3.901M |
| June 30, 2015 | -3.229M |
| March 31, 2015 | -4.373M |
| December 31, 2014 | -7.975M |
Free Cash Flow Range, Past 5 Years
-104.19M
Minimum
Mar 2023
-0.64M
Maximum
Sep 2021
-47.93M
Average
-40.34M
Median
Free Cash Flow Benchmarks
| Boston Scientific Corp | 1.892B |
| Baxter International Inc | 391.00M |
| Masimo Corp | 149.60M |
| Teleflex Inc | 450.04M |
| Perspective Therapeutics Inc | -40.58M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -9.586M |
| Cash from Investing (Quarterly) | 30.56M |
| Cash from Financing (Quarterly) | 9.668M |
| Free Cash Flow Per Share (Quarterly) | -0.2005 |
| Free Cash Flow to Equity (Quarterly) | -11.10M |
| Free Cash Flow to Firm (Quarterly) | -11.04M |
| Free Cash Flow Yield | -1.11% |